Pacuyao, Auring L.
HRN: 23-90-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2023
CEFUROXIME 1.5GM (VIAL)
10/14/2023
10/21/2023
IV
1.5g
Q8
Lacerated Wound, Left Ear And Left Temporal Area
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes